Press Releases

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved its mRNA vaccine against COVID-19 (COVID-19 Vaccine Moderna) for use under Regulation 174. The...

Servier, a global pharmaceutical Group and X-Chem, Inc., a privately held drug discovery company announced a partnership to identify and develop novel small molecules for the treatment of neurological disorders. Under the terms of the multi-target agreement, X-Chem will utilize...

Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, announced it has entered into an exclusive strategic collaboration with clinical AI technology company, Sensyne Health, which is making an equity investment of $10 million in...

Tiziana Life Sciences announced the completion of its clinical study in Brazil investigating nasally administered Foralumab, its proprietary human monoclonal antibody, either alone or in combination with orally administered dexamethasone in COVID-19 patients. The clinical study was completed in collaboration...

AbbVie reported data from a pair of Phase III studies showing that Skyrizi (risankizumab) led to significantly more psoriatic arthritis patients achieving the primary endpoint of at least 20% improvement on American College of Rheumatology (ACR20) criteria than placebo...

Moderna, Inc., biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Recipharm, a leading contract development and manufacturing organization (CDMO), announced that they have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19...

Pfizer Inc. and BioNTech SE announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s...